Biblio

Found 5 results

Filters: Author is Bauman, Julie E [Clear All Filters]

2023

Bauman JE, Saba NF, Roe D, Bauman JR, Kaczmar J, Bhatia A, Muzaffar J, Julian R, Wang S, Bearelly S et al.. 2023. Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer.. J Clin Oncol. 41(22):3851-3862.

2022

Groysman M, Yi SK, Robbins JR, Hsu CC, Julian R, Bauman JE, Baker A, Wang SJ, Bearelly S. 2022. The impact of socioeconomic and geographic factors on access to transoral robotic/endoscopic surgery for early stage oropharyngeal malignancy.. Am J Otolaryngol. 43(1):103243.

Lawson-Michod KA, Le CH, Tranesh G, Thomas PC, Bauman JE. 2022. Precision medicine: Sustained response to erdafitinib in FGFR2-mutant, multiply recurrent ameloblastoma.. Cancer Rep (Hoboken). :e1656.

Qureshy Z, Li H, Zeng Y, Rivera J, Cheng N, Peterson CN, Kim M-O, Ryan WR, Ha PK, Bauman JE et al.. 2022. STAT3 Activation as a Predictive Biomarker for Ruxolitinib Response in Head and Neck Cancer.. Clin Cancer Res. 28(21):4737-4746.

2021

Centuori SM, Caulin C, Bauman JE. 2021. Precision and Immunoprevention Strategies for Tobacco-Related Head and Neck Cancer Chemoprevention.. Curr Treat Options Oncol. 22(6):52.